Palisade Bio - PALI Company Short-Term Debt

Graphic logo of Palisade Bio, Inc. (PALI)

Palisade Bio, Inc. (PALI) disciplined management is effectively optimizing costs, leveraging LB1148 patent protections and strict FDA oversight. This chart of share price quotes demonstrates dynamics under the 0.00 metric. The business is based on creating unique barrier therapy methods that minimize inflammatory processes and accelerate patient recovery following complex abdominal surgical interventions.

PALI (palisadebio.com) Company Short-Term Debts history from 07/04/2022 to 10/29/2026

Summary analytical data breakdowns for Palisade Bio Inc. (PALI)

- price and consensus price forecast:
Price Chart Palisade Bio|PALI - Fair Value Consensus
- market capitalization data:
Market Value Palisade Bio, Inc.|PALI - Real Price to Acquire Entire Company
- book capitalization data:
Book Value per Share Palisade Bio|PALI - Book Capitalization|Market Cap to Net Assets Ratio palisadebio.com|PALI - Aggregate Asset Value
- debt and liquidity data:
Total Debt to Capital Palisade Bio, Inc.|PALI - Long-Term Indebtedness to Equity|Short-Term Debt to Capital Palisade Bio, Inc.|PALI - Company Total Debt Obligations|Debt to Book Value Palisade Bio, Inc.|PALI - Amount of Long-Term Liabilities|Company Short-Term Debt Palisade Bio
Initial company analysis:PALI (Palisade Bio)
Brand item of Palisade Bio Inc.

For Palisade Bio, Inc., which focuses on clinical developments without significant technological impact, the short-term loan capital dynamics on GURU.Markets reflect the operational liquidity required to maintain current activities. This indicator measures the volume of liabilities with a maturity of up to one year, allowing investors to assess the balance between utilizing borrowed funds for expansion and the risk of losing financial stability.

Competitor analysis for Palisade Bio, Inc.

Company Short-Term Debt Phathom Pharmaceuticals, Inc. (PHAT)|TERN: Company Short-Term Loans and Borrowings|IRWD (ironwoodpharma.com) - Company Short-Term Debt|Curanex Pharmaceuticals (CURX) - Company Current Liabilities|IMRN (Immuron Ltd) - Company Short-Term Debts|Company Short-Term Debts evokepharma.com (EVOK)|Entero Therapeutics, Inc. (ENTO) - Company Current Liabilities|Company Short-Term Loans and Borrowings redhillbio.com (RDHL)|JAGX (Jaguar Animal Health) - Company Short-Term Debts|Short-Term Indebtedness Biora Therapeutics, Inc BIOR|Company Short-Term Debts MORF (Morphic Holding, Inc.)